About Us
|
contact Us
|
Sitemap
Call us: +1-855-455-8662
|
Home
Business Solutions
Business Research Reports
Business Consulting
On-site Implementation & Training Programs
Industry Trackers
Subscription Solutions
Industry Reports
News
Press
Login
Register
Home
Market Research
Bioresorbable Vascular Scaffold Market Expected to Grow at 10.3% by 2027
Bioresorbable Vascular Scaffold Market By Material (Polymer Based Stents, Metallic Stents), By Disease Indication (Coronary Heart Disease, Peripheral Artery Disease, Other Cardiovascular Diseases), By End-user (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) - Growth, Future Prospects & Competitive Analysis, 2019 – 2027
25 Aug 2019
Format
Request Sample
Report Summary
Table of contents
list of tables
list of figures
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Bioresorbable Vascular Scaffold Market
2.2. Global Bioresorbable Vascular Scaffold Market, By Material, 2024 (US$ Million)
2.3. Global Bioresorbable Vascular Scaffold Market, By Disease Indication, 2024 (US$ Million)
2.4. Global Bioresorbable Vascular Scaffold Market, By End User, 2024 (US$ Million)
2.5. Global Bioresorbable Vascular Scaffold Market, By Geography, 2024 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2024
3. Bioresorbable Vascular Scaffold Market: Competitive Analysis
3.1. Market Positioning of Key Bioresorbable Vascular Scaffold Market Vendors
3.2. Strategies Adopted by Bioresorbable Vascular Scaffold Market Vendors
3.3. Key Industry Strategies
4. Bioresorbable Vascular Scaffold Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Bioresorbable Vascular Scaffold Market Value, 2023 - 2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2024 Versus 2033
5.3. Market Segmentation
5.3.1. Polymer Based Stents
5.3.2. Metallic Stents
6. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2024 Versus 2033
6.3. Market Segmentation
6.3.1. Coronary Heart Disease
6.3.2. Peripheral Artery Disease
6.3.3. Other Cardiovascular Diseases
7. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2024 Versus 2033
7.3. Market Segmentation
7.3.1. Hospitals
7.3.2. Specialty Clinics
7.3.3. Ambulatory Surgical Centers
8. North America Bioresorbable Vascular Scaffold Market, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
8.3. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
8.4. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
8.5.Bioresorbable Vascular Scaffold Market: By Region, 2023-2033, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
8.5.1.1.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
8.5.1.1.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
8.5.1.2.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
8.5.1.2.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
8.5.1.3.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
8.5.1.3.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
9. UK and European Union Bioresorbable Vascular Scaffold Market, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
9.3. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
9.4. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
9.5.Bioresorbable Vascular Scaffold Market: By Region, 2023-2033, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
9.5.1.1.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
9.5.1.1.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
9.5.1.2.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
9.5.1.2.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
9.5.1.3.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
9.5.1.3.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
9.5.1.4.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
9.5.1.4.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
9.5.1.5. France
9.5.1.5.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
9.5.1.5.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
9.5.1.5.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
9.5.1.6.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
9.5.1.6.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
10. Asia Pacific Bioresorbable Vascular Scaffold Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
10.3. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
10.4. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
10.5.Bioresorbable Vascular Scaffold Market: By Region, 2023-2033, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
10.5.1.1.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
10.5.1.1.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
10.5.1.2.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
10.5.1.2.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
10.5.1.3. India
10.5.1.3.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
10.5.1.3.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
10.5.1.3.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
10.5.1.4.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
10.5.1.4.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
10.5.1.5.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
10.5.1.5.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
10.5.1.6.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
10.5.1.6.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
11. Latin America Bioresorbable Vascular Scaffold Market, 2023-2033, USD (Million)
11.1. Market Overview
11.2. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
11.3. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
11.4. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
11.5.Bioresorbable Vascular Scaffold Market: By Region, 2023-2033, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
11.5.1.1.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
11.5.1.1.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
11.5.1.2.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
11.5.1.2.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
11.5.1.3.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
11.5.1.3.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
12. Middle East and Africa Bioresorbable Vascular Scaffold Market, 2023-2033, USD (Million)
12.1. Market Overview
12.2. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
12.3. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
12.4. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
12.5.Bioresorbable Vascular Scaffold Market: By Region, 2023-2033, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
12.5.1.1.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
12.5.1.1.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
12.5.1.2.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
12.5.1.2.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Bioresorbable Vascular Scaffold Market: By Material, 2023-2033, USD (Million)
12.5.1.3.2. Bioresorbable Vascular Scaffold Market: By Disease Indication, 2023-2033, USD (Million)
12.5.1.3.3. Bioresorbable Vascular Scaffold Market: By End User, 2023-2033, USD (Million)
13. Company Profile
13.1. Cook Medical
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Medtronic, plc.
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Abbott Laboratories
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Stentys SA
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. C. R. Bard, Inc.
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. MAQUET Holding B.V. & Co. KG
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Boston Scientific Corporation
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Terumo Corporation
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. W.L. Gore & Associates
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Boston Scientific Corporation
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. AngioDynamics, Inc.
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. Vygon Ltd.
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives
Choose Licence Type
Single User Licence
$4500
Multi User license
$6500
Corporate license
$9000
Buy Now
Quick Contact
+1-855-455-8662
+91 77559-81103
sales@acutemarketreports.com
View Other Reports
Automotive
986
Chemicals and Materials
684
Consumer Goods
184
Energy
124
Food & Beverages
321
Medical Devices
178
Pharmaceutical & Healthcare
78
Technology
234